Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Intestinal Content Sample Sequencing

PROVIDER: PRJNA593706 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10592600_1.fastq.gz	Fastqsanger.gz
	SRR10592600_2.fastq.gz	Fastqsanger.gz
	SRR10592601_1.fastq.gz	Fastqsanger.gz
	SRR10592601_2.fastq.gz	Fastqsanger.gz
	SRR10592602_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 40

Similar Datasets

intestinal content sample

Project description:intestinal content sample Raw sequence reads

| PRJNA541110 | ENA

Project description:Mice intestinal content metagenome sequencing

| PRJNA885613 | ENA

Project description:intestinal sample sequencing

| PRJNA689292 | ENA

Project description:Intestinal sample sequencing

| PRJNA875282 | ENA

Project description:intestinal sample sequencing

| PRJNA678137 | ENA

Project description:Intestinal sample sequencing

| PRJNA718150 | ENA

Project description:giraffe intestinal sample sequencing

| PRJNA727450 | ENA

Project description:Probiotic-intestinal sample sequencing

| PRJNA729733 | ENA

Project description:duck intestinal sample sequencing

| PRJNA686253 | ENA

High-content, targeted RNA-seq screening in organoids for drug discovery in colorectal cancer

Project description:We present TORNADO-seq —a high-throughput, a high-content drug discovery platform that for the first time uses next-generation sequencing (NGS) based, targeted RNA-seq in organoids monitoring the expression of 206 genes for the evaluation of complex mixtures of cellular phenotypes. TORNADO-seq is a fast, highly-reproducible, time- and cost-effective (5$ per sample including sequencing cost) method that we used to find drugs that enrich for differentiated cell phenotypes in intestinal organoids. These drugs are highly efficacious against cancer compared to wild type organoids and may therefore become promising candidates in CRC treatment. Further, TORNADO-seq facilitated in-depth insight on the mode of action of these drugs.

2021-03-10 | GSE157167 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data